Loading…
Rezolute, Inc. is projected to rise to $8.04 by 2027, a +70% move from its current price of $4.72. RZLT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $4.54 | $4.73 | $4.92 | +0.14% |
| Aug 4 | $4.47 | $4.73 | $5.01 | +0.27% |
| Aug 5 | $4.42 | $4.74 | $5.08 | +0.41% |
| Aug 6 | $4.38 | $4.75 | $5.14 | +0.55% |
| Aug 7 | $4.35 | $4.75 | $5.20 | +0.68% |
| Aug 8 | $4.31 | $4.76 | $5.25 | +0.82% |
| Aug 9 | $4.29 | $4.77 | $5.30 | +0.96% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.29 | $4.77 | $5.30 | +0.96% |
| Week 2 | $4.14 | $4.81 | $5.59 | +1.93% |
| Week 3 | $4.04 | $4.86 | $5.84 | +2.91% |
| Week 4 | $3.97 | $4.90 | $6.06 | +3.90% |
| Week 5 | $3.91 | $4.95 | $6.28 | +4.89% |
| Week 6 | $3.86 | $5.00 | $6.48 | +5.90% |
| Week 7 | $3.81 | $5.05 | $6.68 | +6.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rezolute, Inc. is a Healthcare company described as a late-stage rare disease company focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism.
The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Rezolute, Inc. (RZLT) is a healthcare stock currently priced at $4.70 per share, with a market capitalization of $452.57M, and it is ranked 3108 by market cap. This places the company among mid-cap peers in a niche rare-disease space.
A major floor 43.0% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 12.5% above — a clean break opens room to run.
A major ceiling 21.6% above — clearing it would confirm fresh momentum.
Key RZLT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RZLT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.83 | Sell | $4.82 | Sell |
| MA 10 | $4.90 | Sell | $4.85 | Sell |
| MA 20 | $4.85 | Sell | $4.82 | Sell |
| MA 50 | $4.49 | Buy | $4.52 | Buy |
| MA 100 | $3.82 | Buy | $4.29 | Buy |
| MA 200 | $4.71 | Buy | $4.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.04 | Neutral |
| Stoch RSI (14) | 31.31 | Neutral |
| CCI (20) | -50.00 | Neutral |
| Williams %R (14) | -62.77 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -0.42 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 37.23 | Neutral |
| TRIX (15) | 0.36 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 42.86 | Neutral |
| Momentum (10) | 0.11 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 4.72 | Sell |
| ADX (14) | 14.90 | Neutral |
| ATR (14) | 0.18 | Info |
The near-term technical picture is neutral, with RSI14 at 50 indicating neither overbought nor oversold conditions. The stock trades around key moving averages, with SMA50 at $4.43 and SMA200 at $4.75.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.91 | $4.72 | $7.82 | 0% | Neutral | |
| $6.14 | $8.04 | $11.28 | +70% | Bullish | |
| $7.85 | $10.73 | $15.86 | +127% | Bullish | |
| $8.57 | $12.16 | $18.69 | +158% | Bullish | |
| $9.10 | $13.33 | $21.19 | +182% | Bullish | |
| $9.70 | $14.65 | $23.96 | +210% | Bullish | |
| $11.03 | $17.13 | $28.74 | +263% | Bullish | |
| $15.24 | $24.32 | $41.74 | +415% | Bullish | |
| $17.83 | $29.19 | $51.16 | +518% | Bullish | |
| $18.87 | $31.67 | $56.58 | +571% | Bullish | |
| $29.53 | $55.63 | $107.67 | +10.8x | Bullish | |
| $51.82 | $115.15 | $249.75 | +23.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.91 | $4.72 | $6.28 | +0.00% |
| September 2026 | $4.39 | $5.27 | $6.55 | +11.58% |
| October 2026 | $4.41 | $5.35 | $6.75 | +1.50% |
| November 2026 | $4.71 | $5.75 | $7.35 | +7.65% |
| December 2026 | $4.92 | $6.05 | $7.82 | +5.17% |
Click any year to see its month-by-month RZLT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RZLT is projected to trade between $1.91 and $7.82, averaging $4.72 — a potential gain of 0% from today's $4.72. A consolidation phase looks the most probable path here.
Rezolute, Inc.'s 2027 outlook centres on $8.04, within a $6.14 to $11.28 range. That is up +70% on the projected 2026 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2028, RZLT could reach as high as $15.86, with a base case around $10.73 and support toward $7.85 — roughly +127% from $4.72. Buyers look set to stay in control over this stretch.
Expect RZLT to range from $8.57 to $18.69 through 2029. The $12.16 average target implies a +158% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The RZLT price prediction for 2030 points to an average of $13.33 (low $9.10, high $21.19) — a potential gain of +182% on today's $4.72. Buyers look set to stay in control over this stretch.
In 2031, RZLT is projected to trade between $9.70 and $23.96, averaging $14.65 — a potential gain of +210% from today's $4.72. That is up +10% on the projected 2030 average. Momentum favours further upside here.
Rezolute, Inc.'s 2032 outlook centres on $17.13, within a $11.03 to $28.74 range. That is up +17% on the projected 2031 average. That marks a +263% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, RZLT could reach as high as $41.74, with a base case around $24.32 and support toward $15.24 — roughly +415% from $4.72. Momentum favours further upside here.
Expect RZLT to range from $17.83 to $51.16 through 2034. The $29.19 average target implies a +518% move from current prices. That is up +20% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The RZLT price prediction for 2035 points to an average of $31.67 (low $18.87, high $56.58) — a potential gain of +571% on today's $4.72. Momentum favours further upside here.
In 2040, RZLT is projected to trade between $29.53 and $107.67, averaging $55.63 — a potential gain of +10.8x from today's $4.72. That is up +76% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Rezolute, Inc.'s 2050 outlook centres on $115.15, within a $51.82 to $249.75 range. That is up +107% on the projected 2040 average. That marks a +23.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in RZLT today (≈ 211.864407 RZLT) could be worth
$24,396.4
+$23,396.4 (+2340%) by 2050 · US Dollar
Based on the average projected RZLT price of $115.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RZLTwould be worth at today's price.
$1,000 invested in RZLT on Jul 31, 2025 (≈ 168.067232 RZLT) would be worth
$793.28
-$206.72 (-20.7%) today · 0.79× · US Dollar
Based on a RZLT entry price of $5.95 vs. today's $4.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.99 | $945.89 | -5.4% |
| 1 month ago | $4.95 | $953.54 | -4.6% |
| 3 months ago | $3.3 | $1,430.3 | +43.0% |
| 6 months ago | $3.24 | $1,456.79 | +45.7% |
| 1 year ago | $5.95 | $793.28 | -20.7% |
| All time (5.0y) ago | $11 | $429.09 | -57.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RZLT forecast.
Our base-case forecast reaches $9.40 around 2028.
Implied market cap at $9.40: $905.15M
The multi-year forecast points to a bullish path beyond 2026, with 2026 at an average of $4.70 and rising to $8.06 in 2027, $13.37 in 2030, $56.09 in 2040, and $115.40 in 2050. The implied upside is reflected in the rising forecasted averages and higher max targets over time, with max forecasts of $7.85 (2026), $11.37 (2027), $21.41 (2030), $109.85 (2040), and $253.76 (2050). The projected ROI grows from 0 in 2026 to 71.5 in 2027, 131.6 in 2028, 160.7 in 2029, 184.4 in 2030, 213.8 in 2031, 263.7 in 2032, 418.9 in 2033, 527.9 in 2034, 577.6 in 2035, 1093.5 in 2040, and 2355.4 in 2050, with bullish sentiment continuing across years.
These are estimates, not guarantees, and could be influenced by trial outcomes, regulatory decisions, and broader market dynamics. The asset also shows high volatility, with annualized volatility of 80%.
Tap a question to reveal the answer.
Average price forecast for 2027 is $8.06, with a minimum of $6.13 and a maximum of $11.37. ROI is listed as 71.5 and sentiment is BULLISH.
Forecasts show rising averages beyond 2026 (e.g., 2027 avg $8.06, 2030 avg $13.37, 2040 avg $56.09, 2050 avg $115.40) and increasing max targets, but these are estimates and not guarantees.
Yes, the 2050 forecast includes a max of $253.76 and an avg of $115.40, indicating potential to exceed $100 under the projection.
Average price for 2030 is $13.37, with a minimum of $9.04 and a maximum of $21.41. ROI is 184.4 and sentiment is BULLISH.
Current price is $4.70 and the market cap is $452.57M.
Rezolute, Inc. Community Discussion
0Share your Rezolute, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.